Condition: Non Segmental Vitiligo · Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
This a phase II/III randomized, double-blind, placebo-controlled, parallel group, adaptive design, multi-center study to evaluate the efficacy and safety of ICP-332 in subjects with non-segmental vitiligo。The study consisted an phase 2 part and an phase 3 part.
This description comes directly from the study's public registry record.
Flora Xiang, Doctor · 021-52887775 · flora_xiang@vip.163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | Not Yet Recruiting |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Chao-yang Hospital,Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Tongren Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Chongqing Traditional Chinese Medicine Hospital | Chongqing, Chongqing Municipality, China | Recruiting |
| Union Hospital affiliated to Fujian Medical | Fuzhou, Fujian, China | Not Yet Recruiting |
| The First Affiliated Hospital of Fujian Medical | Fuzhou, Fujian, China | Not Yet Recruiting |
| Sun Yat-sen Memorial Hospital,Sun Yat-sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Deramatology Hospital of Southern Medical Univercity | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Nanfang Hospital | Guangzhou, Guangdong, China | Not Yet Recruiting |
+ 33 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07047612